Showing results (521-530 of 536) with videos related to
Sort By:
Pageof 54
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 29, 1998
[Results of clinical study with epirubicin hydrochloride injectable solution for superficial bladder cancer. IMI28 Injectable Solution Study Group for Superficial Bladder Cancer]T Kotake, T Koyanagi, H Akaza, et al.Clinical Radiology|August 6, 2025
Relationship between maximum injection pressure and extravasation rate of contrast media in computed tomographyN Koori, R Sugai, T Hasegawa, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|December 8, 2000
[Clinicopathological study of the testicular microlithiasis]Y Maeda, K Komatsu, Y Iwasa, et al.The American Journal of Pathology|November 1, 1996
Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancerT Ueda, T Ichikawa, J Tamaru, et al.International Journal of Oncology|May 6, 2011
Detection of RB, p16/CDKN2 and p15(INK4B) gene alterations with immunohistochemical studies in human prostate carcinomasN Konishi, Y Hiasa, T Tsuzuki, et al.The Prostate. Supplement|January 1, 1996
Metastasis suppressor genes for prostate cancerT Ichikawa, N Nihei, H Kuramochi, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 4, 1998
Ex vivo phosphorus magnetic resonance spectroscopy on eye bank corneas and corneal metabolic healthJ V Greiner, T Glonek, J H Lass, et al.Bone Marrow Transplantation|November 6, 2007
Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host diseaseY Wang, Y Ogawa, M Dogru, et al.Eye (London, England)|November 18, 2008
Tear function and lipid layer alterations in dry eye patients with chronic graft-vs-host diseaseY Ban, Y Ogawa, E Goto, et al.Urology|August 12, 1999
Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalitiesK Akakura, S Isaka, S Akimoto, et al.Pageof 54